Price Alert

Inspire Medical Systems I... (INSP)

NYSE: INSP · Real-Time Price · USD

86.65

2.07 (2.45%)

At close: Aug 15, 2025, 2:09 PM

Inspire Medical Systems Statistics

Share Statistics

Inspire Medical Systems has 29.57M shares outstanding. The number of shares has increased by -1.1% in one year.

Shares Outstanding	29.57M
Shares Change (YoY)	-1.1%
Shares Change (QoQ)	-0.89%
Owned by Institutions (%)	99.99%
Shares Floating	27.91M
Failed to Deliver (FTD) Shares	1,198
FTD / Avg. Volume	0.14%

Short Selling Information

The latest short interest is 3.29M, so 11.16% of the outstanding shares have been sold short.

Short Interest	3.29M
Short % of Shares Out	11.16%
Short % of Float	15%
Short Ratio (days to cover)	5.09

Valuation Ratios

The PE ratio is 103.11 and the forward PE ratio is 48.01. Inspire Medical Systems's PEG ratio is -0.29.

PE Ratio	103.11
Forward PE	48.01
PS Ratio	6.87
Forward PS	2.3
PB Ratio	8
P/FCF Ratio	60.55
PEG Ratio	-0.29

Financial Ratio History

Enterprise Valuation

Inspire Medical Systems has an Enterprise Value (EV) of 5.4B.

EV / Sales	6.73
EV / EBITDA	83.03
EV / EBIT	41.45
EV / FCF	59.25

Financial Position

The company has a current ratio of 7.13, with a Debt / Equity ratio of 0.05.

Current Ratio	7.13
Quick Ratio	6.22
Debt / Equity	0.05
Debt / EBITDA	0.49
Debt / FCF	0.35
Interest Coverage	1640.14

Financial Efficiency

Return on Equity is 7.76% and Return on Invested Capital is 4.58%.

Return on Equity	7.76%
Return on Assets	6.62%
Return on Invested Capital	4.58%
Revenue Per Employee	$644.3K
Profits Per Employee	$42.94K
Employee Count	1,246
Asset Turnover	0.99
Inventory Turnover	1.54

Taxes

Income Tax	4.94M
Effective Tax Rate	8.46%

Stock Price Statistics

The stock price has increased by -59.2% in the last 52 weeks. The beta is 1.22, so Inspire Medical Systems's price volatility has been higher than the market average.

Beta	1.22
52-Week Price Change	-59.2%
50-Day Moving Average	127.15
200-Day Moving Average	164.09
Relative Strength Index (RSI)	20.88
Average Volume (20 Days)	834,237

Income Statement

In the last 12 months, Inspire Medical Systems had revenue of 802.8M and earned 53.51M in profits. Earnings per share was 1.8.

Revenue	802.8M
Gross Profit	679.82M
Operating Income	36.08M
Net Income	53.51M
EBITDA	65.03M
EBIT	58.48M
Earnings Per Share (EPS)	1.8

Full Income Statement

Balance Sheet

The company has 150.15M in cash and 31.79M in debt, giving a net cash position of 118.36M.

Cash & Cash Equivalents	150.15M
Total Debt	31.79M
Net Cash	118.36M
Retained Earnings	-291.91M
Total Assets	802.19M
Working Capital	479.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 130.25M and capital expenditures -39.12M, giving a free cash flow of 91.12M.

Operating Cash Flow	130.25M
Capital Expenditures	-39.12M
Free Cash Flow	91.12M
FCF Per Share	3.06

Full Cash Flow Statement

Margins

Gross margin is 84.68%, with operating and profit margins of 4.49% and 6.67%.

Gross Margin	84.68%
Operating Margin	4.49%
Pretax Margin	7.28%
Profit Margin	6.67%
EBITDA Margin	8.1%
EBIT Margin	4.49%
FCF Margin	11.35%

Dividends & Yields

INSP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	0.97%
FCF Yield	1.65%

Dividend Details

Analyst Forecast

The average price target for INSP is $165, which is 107.1% higher than the current price. The consensus rating is "Buy".

Price Target	$165
Price Target Difference	107.1%
Analyst Consensus	Buy
Analyst Count	13

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	30.62
Graham Upside	-61.57%

Scores

Altman Z-Score	12.91
Piotroski F-Score	6